Metastatic Pancreatic Cancer: ASCO Guideline Update

The aim of this work was to provide an update to the ASCO guideline on metastatic pancreatic cancer pertaining to recommendations for therapy options after first-line treatment.ASCO convened an Expert Panel and conducted a systematic review to update guideline recommendations for second-line therapy for metastatic pancreatic cancer.One randomized controlled trial of olaparib versus placebo, one report on phase I and II studies of larotrectinib,...